EUVIMEDEUVIMED entdecken
Crossref

Spatiotemporal EP4–fibulin-1 expression is associated with vascular intimal hyperplasia

Shigekuni Okumura, Sayuki Oka, Takako Sasaki, Marion A Cooley, Yuko Hidaka, Hana Inoue, Hitoshi Nishijima, Shin-Ichiro Ohno, Shota Tanifuji, Mari Kaneko, Takaya Abe, Masahiko Kuroda und 5 weitere

Cardiovascular Research · 2024

DOI: 10.1093/cvr/cvae211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Shigekuni Okumura und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Tokyo Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Receptors, Prostaglandin E, EP4 Subtype, Hyperplasia, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Gefördert von: MEXT/JSPS KAKENHI, S.Okumura, U.Y..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cyclooxygenase-2–derived prostaglandin E2 (PGE2) is thought to promote vascular intimal hyperplasia (IH). It has been reported that the PGE2 receptor EP4 is upregulated in injured vessels and that EP4 signalling in vascular smooth muscle cells (VSMCs) promotes IH. In contrast, EP4 in endothelial cells has been demonstrated to restrain IH. We aimed to investigate spatiotemporal expression of EP4 and whether modulating EP4 signalling could be a viable therapeutic strategy. Methods and results We generated EP4 reporter mice (Ptger4-IRES-nlsLacZ) and found temporary but prominent EP4 expression in VSMCs of the proliferative neointima 2 weeks after femoral artery wire injury. Injury-induced IH was diminished in VSMC-targeted EP4 heterozygous deficient mice (Ptger4fl/+;SM22-Cre) 2 and 4 weeks after vascular injury compared to that in SM22-Cre, whereas injury-induced IH was exacerbated in VSMC-targeted EP4-overexpressing mice (Ptger4-Tg) compared to controls (non-Tg). We then investigated the downstream signalling of EP4 in VSMCs. Stimulation of EP4 increased mRNA and protein levels of the glycoprotein fibulin-1 in Ptger4-Tg VSMCs. Fibulin-1C recombinant proteins increased VSMC proliferation and migration through transforming growth factor (TGF)- β/Smad3, and EP4-mediated proliferation and migration were attenuated in Fbln1fl/fl;SM22-Cre VSMCs and in CRISPR/Cas9-mediated Fbln1 knockdown in Ptger4-Tg VSMCs. We generated multiple deletion mutants of fibulin-1C and found that EGF-like modules 6–8 appear to be involved in fibulin-1-mediated proliferation. Among binding partners of fibulin-1, extracellular matrix protein 1 (ECM1) was also upregulated by EP4 stimulation, and fibulin-1C and ECM1 proteins additively enhanced VSMC proliferation and migration. Injury-induced IH was attenuated in VSMC-targeted fibulin-1 deletion mice (Fbln1fl/fl;SM22-Cre) compared to Fbln1fl/fl. Furthermore, systemic EP4 antagonist administration reduced injury-induced IH in wild-type mice.

Conclusion

EP4 was upregulated in VSMCs of proliferative IH, and EP4 signalling promoted IH, at least in part through fibulin-1. An EP4 antagonist might be considered as a therapeutic strategy for IH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Prostaglandin E, EP4 SubtypeHyperplasiaMuscle, Smooth, VascularMyocytes, Smooth MuscleSignal TransductionNeointimaCell ProliferationDisease Models, AnimalFemoral ArteryVascular System InjuriesMice, Inbred C57BLMice, KnockoutAnimalsCells, CulturedExtracellular Matrix ProteinsTime FactorsMaleVascular RemodelingMicrofilament ProteinsSmad3 ProteinCell MovementMuscle Proteins

Stichwörter der Autor:innen

Fibulin-1NeointimaProstaglandin EProstanoid receptor EP4Vascular injuries

Substanzen

Receptors, Prostaglandin E, EP4 SubtypePtger4 protein, mouseExtracellular Matrix ProteinsMicrofilament ProteinsSmad3 ProteinTagln protein, mouseSmad3 protein, mouseMuscle Proteins

Autor:innen und Institutionen

  • Department of Physiology, Tokyo Medical University, Tokyo, Japan.
  • Department of Emergency and Critical Care Medicine, Tokyo Medical University, Tokyo, Japan.
  • Department of Pharmacology, Faculty of Medicine, Oita University, Oita, Japan.
  • Department of Oral Biology and Diagnostic Sciences, Augusta University, Augusta, GA, USA.
  • Department of Immunology, Tokyo Medical University, Tokyo, Japan.
  • Department of Molecular Pathology, Tokyo Medical University, Tokyo, Japan.

ORCID-Profile: Utako Yokoyama

Förderung

  • MEXT/JSPS KAKENHI
  • S.Okumura
  • U.Y.
  • Japan Agency for Medical Research and Development
  • Lydia O'leary Memorial PIAS Dermatological Foundation/Elastin
  • Tokyo Medical University KAKENHI
  • Tokyo Medical University
  • Lydia O’leary Memorial PIAS Dermatological Foundation/Elastin

Zitieren

APA

Okumura, S., Oka, S., Sasaki, T., Cooley, M. A., Hidaka, Y., Inoue, H., Nishijima, H., Ohno, S. I., Tanifuji, S., Kaneko, M., Abe, T., Kuroda, M., Yokosuka, T., Breyer, R. M., Homma, H., Kato, Y., & Yokoyama, U. (2024). Spatiotemporal EP4–fibulin-1 expression is associated with vascular intimal hyperplasia. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae211

Vancouver

Okumura S, Oka S, Sasaki T, Cooley MA, Hidaka Y, Inoue H, et al. Spatiotemporal EP4–fibulin-1 expression is associated with vascular intimal hyperplasia. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae211

BibTeX
@article{Okumura2024,
  author = {Okumura, Shigekuni and Oka, Sayuki and Sasaki, Takako and Cooley, Marion A and Hidaka, Yuko and Inoue, Hana and Nishijima, Hitoshi and Ohno, Shin-Ichiro and Tanifuji, Shota and Kaneko, Mari and Abe, Takaya and Kuroda, Masahiko and Yokosuka, Tadashi and Breyer, Richard M and Homma, Hiroshi and Kato, Yuko and Yokoyama, Utako},
  title = {Spatiotemporal EP4–fibulin-1 expression is associated with vascular intimal hyperplasia},
  journal = {Cardiovascular Research},
  year = {2024},
  doi = {10.1093/cvr/cvae211}
}
Kostenlos starten →